ARVINAS, INC. — Institutional Ownership
Which tracked institutions hold ARVN, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
25
Funds holding
$152951605
Total value held
Buying
18 added/new · 6 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $63231810 | 7609123 | +811539 | +11.94% |
| 2 | Pfizer Inc | $27662520 | 3457815 | — | Held |
| 3 | State Street Corp | $18256006 | 2196872 | +368400 | +20.15% |
| 4 | Federated Hermes, Inc. | $11268626 | 1356032 | +1356032 | NEW BUY |
| 5 | Goldman Sachs Group Inc | $5325139 | 640811 | -116064 | -15.33% |
| 6 | Northern Trust Corp | $5113110 | 615296 | +94341 | +18.11% |
| 7 | Morgan Stanley | $4177897 | 502755 | -171963 | -25.49% |
| 8 | Ubs Group Ag | $3695241 | 444674 | +444674 | NEW BUY |
| 9 | Franklin Resources Inc | $3044975 | 366423 | +149635 | +69.02% |
| 10 | Bank Of New York Mellon Corp | $2119021 | 254997 | +18283 | +7.72% |
| 11 | Bank Of America Corp /De/ | $2101923 | 252939 | +136139 | +116.56% |
| 12 | Invesco Ltd. | $2060216 | 247920 | +247920 | NEW BUY |
| 13 | Ameriprise Financial Inc | $1540234 | 185347 | +185347 | NEW BUY |
| 14 | Wells Fargo & Company/Mn | $884275 | 106411 | +52748 | +98.29% |
| 15 | Barclays Plc | $697416 | 83925 | +27568 | +48.92% |
| 16 | Citigroup Inc | $484166 | 58263 | +15957 | +37.72% |
| 17 | Sei Investments Co | $335486 | 40372 | -38215 | -48.63% |
| 18 | Raymond James Financial Inc | $308151 | 37082 | +1850 | +5.25% |
| 19 | Jpmorgan Chase & Co | $257222 | 31028 | -112285 | -78.35% |
| 20 | Janus Henderson Group Plc | $247319 | 23365 | +23365 | NEW BUY |
| 21 | Prudential Financial Inc | $83516 | 10050 | +10050 | NEW BUY |
| 22 | Pnc Financial Services Group, Inc. | $28080 | 3379 | -179 | -5.03% |
| 23 | Royal Bank Of Canada | $27000 | 3187 | +2893 | +984.01% |
| 24 | Us Bancorp \De\ | $1737 | 209 | -672 | -76.28% |
| 25 | Amalgamated Financial Corp. | $519 | 7712 | +7712 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.